Literature DB >> 3263722

Evidence for a biphasic memory T-cell response to high dose BCG vaccination in mice.

I M Orme1.   

Abstract

Memory immunity in mice to BCG vaccination is mediated by Thy-1.2+ L3T4+ Lyt-2- cyclophosphamide-resistant T-lymphocytes. The time required for the emergence of acquired memory immunity was inversely proportional to the BCG inoculum size, although the level of memory expressed, once established, was equivalent regardless of the original dose of BCG administered. In mice given a high intravenous dose (10(8)) of BCG, an apparently biphasic memory response was observed, initially peaking on day 15-20, then declining for 10 days or so before increasing again to maximal levels between day 30 and 60 of the infection. This trough in resistance was not due to an active immunosuppressive mechanism; instead, it is suggested that it represents an initial loss or consumption of memory T-cells generated early during the infection which are stimulated to give rise to a state of active immunity as a result of the persisting high mycobacterial load.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263722     DOI: 10.1016/0041-3879(88)90075-x

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  6 in total

1.  Patterns of IL-2 production and utilization in mice heavily infected with Mycobacterium bovis BCG reflect the phase of protective immunity being expressed.

Authors:  E S Miller; I M Orme
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

2.  Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice.

Authors:  J H Cox; B C Knight; J Ivanyi
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

3.  Antigen-dependent in vitro culture of protective T cells from BCG-primed mice.

Authors:  S D'Souza; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

4.  Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae.

Authors:  K W Baumgart; K R McKenzie; A J Radford; I Ramshaw; W J Britton
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis.

Authors:  Marcela I Henao-Tamayo; Diane J Ordway; Scott M Irwin; Shaobin Shang; Crystal Shanley; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

6.  Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.

Authors:  R J North; A A Izzo
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.